Anaphylaxis Cases Reported at 2.5 Per Million Moderna Vaccine Shots
Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions
Viral Infections
US to Get Fewer Vials of Pfizer COVID-19 Vaccine
Pharmacists found they could get an extra dose out of Pfizer vials that were supposed to contain only five doses
Early Data Show Antibody Cocktail Prevents Symptomatic COVID-19 Infection
REGEN-COV consists of 2 potent, virus-neutralizing antibodies that bind noncompetitively to the receptor binding domain of the SARS-CoV-2 spike protein.
Bamlanivimab Plus Etesevimab Cuts COVID-19 Hospitalization, Deaths
The combination therapy reduced the risk of hospitalization or death by 70%.
Merck Ends Development of Two COVID-19 Vaccine Candidates
While both candidates were found to be generally well tolerated, findings showed immune responses that were inferior to those seen after natural infection or those reported with other COVID-19 vaccines.
Adults Delaying Even Emergency Care During COVID-19
More than half report being hesitant going to doctor or hospital when COVID-19 cases are high
Moderna COVID-19 Vaccine Active Against Emerging Variants
In the US, a phase 1 study will evaluate mRNA-1273.351, an emerging variant booster candidate against the B.1.351 variant.
Cabenuva Approved as First Long-Acting Injectable for HIV Treatment
The approval of Cabenuva was based on data from two phase 3 trials which included 1182 HIV-infected adults who were virologically suppressed (HIV-1 RNA less than 50 copies/mL) prior to initiation.
Either Trivalent Flu Vaccine Safe for Use in Seniors
Trivalent adjuvanted, trivalent high-dose inactivated influenza vaccines comparable for moderate-to-severe injection-site pain in adults 65 years and older
MPR Weekly Dose Podcast Episode 65
On this week’s MPR pod we take a look at the current status of Johnson & Johnson’s COVID-19 vaccine candidate; Considerations in assessing blood donors during pandemic times; A newly approved drug to treat heart failure; Promising results for a potential Alzheimer treatment; And changes declared for vinca alkaloid labeling.
